Merck Victrelis Glowing Recommendation From NICE At Odds With IQWiG
This article was originally published in The Pink Sheet Daily
Executive Summary
The contrasting views in Germany and England for the hepatitis C product underscore the difference between IQWiG’s purely scientific assessment and NICE’s focus on cost-effectiveness.